Profiling whole-tissue metabolic reprogramming during cutaneous poxvirus infection and clearance

Luxin Pei1, Kirsten E Overdahl2, John P Shannon1

  • 1Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Journal of Virology
|November 27, 2023
PubMed
Abstract

Insights

This study reveals metabolic shifts during vaccinia virus (VACV) skin infection in mice. Key metabolites like nucleotides and glutamine change, offering insights into host defense against poxviruses.

Area of Science:

  • Virology
  • Immunology
  • Metabolomics

Background:

  • Human poxvirus infections, including Mpox, pose significant public health challenges.
  • The vaccinia virus (VACV) mouse model is crucial for studying anti-poxvirus immunity.
  • Metabolic changes during VACV skin infection in vivo are poorly understood.

Purpose of the Study:

  • To investigate the in vivo metabolic alterations in skin during VACV infection.
  • To identify key metabolites associated with host response and viral clearance.

Main Methods:

  • Untargeted mass spectrometry profiling of VACV-infected mouse skin.
  • Complementary analyses using flow cytometry and transcriptomics.

Main Results:

  • VACV infection significantly alters the skin metabolome.
  • Differential expression of nucleotides, itaconic acid, and glutamine was observed.
  • Metabolic pathways reflect increased energy demands of infected and immune cells.

Conclusions:

  • The study elucidates virus-specific and immune-mediated metabolic pathways during cutaneous poxvirus infection.
  • Identified metabolites may play a role in the clearance of poxvirus infections.
  • Findings contribute to understanding host-pathogen metabolic interactions.